{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:00:20Z","timestamp":1791295220335,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06646"],"award-info":[{"award-number":["21K06646"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K11100"],"award-info":[{"award-number":["21K11100"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e21891","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T23:39:53Z","timestamp":1699313993000},"page":"e21891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system"],"prefix":"10.1016","volume":"9","author":[{"given":"Sakiko","family":"Hirofuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koumi","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Oura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanaka","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Masuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-5522","authenticated-orcid":false,"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e21891_bib1","series-title":"Jutoku Fukusayo Shikkanbetsu Taiou Manual: Akusei Shoukougun (The Manual for Handling Disorders Due to Adverse Drug Reactions: Neuroleptic Malignant Syndrome)","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e21891_bib2","series-title":"Neuroleptic Malignant Syndrome","author":"Simon","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e21891_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","article-title":"Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital","volume":"143","author":"Pope","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/pcn.12793","article-title":"Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database","volume":"7","author":"Anzai","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.heliyon.2023.e21891_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159X13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective","volume":"13","author":"Tse","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2023.e21891_bib6","first-page":"CS71","article-title":"Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics","volume":"9","author":"Kami\u0144ska","year":"2003","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.heliyon.2023.e21891_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.redar.2020.10.017","article-title":"Neuroleptic malignant syndrome in a postoperative patient: a case report","volume":"69","author":"Fervienza","year":"2022","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"key":"10.1016\/j.heliyon.2023.e21891_bib8","series-title":"Data Mining Applications in Engineering and Medicine","first-page":"265","article-title":"Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS)","author":"Poluzzi","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e21891_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/pds.5108","article-title":"Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database","volume":"29","author":"Hasegawa","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.heliyon.2023.e21891_bib10","series-title":"Cluster Analysis","author":"Everitt","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e21891_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/biom.12647","article-title":"Statistical significance for hierarchical clustering","volume":"73","author":"Kimes","year":"2017","journal-title":"Biometrics"},{"key":"10.1016\/j.heliyon.2023.e21891_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4338\/ACI-2015-06-RA-0076","article-title":"Association patterns in open data to explore ciprofloxacin adverse events","volume":"6","author":"Yildirim","year":"2015","journal-title":"Appl. Clin. Inf."},{"key":"10.1016\/j.heliyon.2023.e21891_bib13","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2105-11-S9-S7","article-title":"Mining multi-item drug adverse effect associations in spontaneous reporting systems","volume":"11","author":"Harpaz","year":"2010","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2023.e21891_bib14","first-page":"758","article-title":"Automated knowledge extraction for decision model construction: a data mining approach","volume":"2003","author":"Zhu","year":"2003","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.heliyon.2023.e21891_bib15","series-title":"The Classification of Psychopathology: Neo-Kraepelinian and Quantitative Approaches, Softcover Reprint of the Original","first-page":"328","author":"Blashfield","year":"1984"},{"key":"10.1016\/j.heliyon.2023.e21891_bib16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.pnpbp.2008.09.025","article-title":"Identifying the profile of optimal candidates for antipsychotic depot therapy: a cluster analysis","volume":"32","author":"Heres","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eurpsy.2015.11.007","article-title":"A cluster-analytical approach toward real-world outcome in outpatients with stable schizophrenia","volume":"32","author":"Rocca","year":"2016","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e21891_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217951","article-title":"Analysis of drug-induced hearing loss by using a spontaneous reporting system database","volume":"14","author":"Tanaka","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e21891_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40780-018-0129-8","article-title":"Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database","volume":"4","author":"Hatahira","year":"2018","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.heliyon.2023.e21891_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182045","article-title":"Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database","volume":"12","author":"Hasegawa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e21891_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.heliyon.2023.e21891_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.focus.20200051","article-title":"Contrasting typical and atypical antipsychotic drugs","volume":"19","author":"Meltzer","year":"2021","journal-title":"Focus"},{"key":"10.1016\/j.heliyon.2023.e21891_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21891_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","article-title":"Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies","volume":"121","author":"Verdoux","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.heliyon.2023.e21891_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.heliyon.2023.e21891_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2023.e21891_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2002-31518","article-title":"Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient","volume":"35","author":"Bottlender","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib29","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs","volume":"63","author":"Caroff","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib30","first-page":"125","article-title":"Association between antipsychotic use and extrapyramidal syndrome: data mining of the FDA adverse event reporting system and the Japanese adverse drug event report database","volume":"17","author":"Hosomi","year":"2015","journal-title":"Jpn J Drug Inform"},{"key":"10.1016\/j.heliyon.2023.e21891_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"Peluso","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ebmental-2012-100850","article-title":"No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics","volume":"15","author":"Carnahan","year":"2012","journal-title":"Evid. Base Ment. Health"},{"key":"10.1016\/j.heliyon.2023.e21891_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00008571-200008000-00010","article-title":"CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10","volume":"10","author":"Nishida","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.heliyon.2023.e21891_bib34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1819.2005.01405.x","article-title":"CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report","volume":"59","author":"Kato","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.heliyon.2023.e21891_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00228-007-0355-8","article-title":"Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome","volume":"63","author":"Kato","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21891_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e21891_bib38","article-title":"Highlights of prescribing information, SAPHRIS (asenapine) sublingual tablets","year":"2007","journal-title":"MERCK & CO., INC"},{"key":"10.1016\/j.heliyon.2023.e21891_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cpt.1768","article-title":"A scoping review of the evidence behind cytochrome P450 2D6 isoenzyme inhibitor classifications","volume":"108","author":"Cicali","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2023.e21891_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40360-021-00513-x","article-title":"Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese Adverse Drug Event Report database","volume":"22","author":"Nakao","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.heliyon.2023.e21891_bib42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/sim.8457","article-title":"Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System","volume":"39","author":"Wang","year":"2020","journal-title":"Stat. Med."},{"key":"10.1016\/j.heliyon.2023.e21891_bib43","series-title":"A Systematic Approach to Improving the Reliability and Scale of Evidence from Health Care Data","author":"Schuemie","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e21891_bib44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/ije\/dyy120","article-title":"Evaluating large-scale propensity score performance through real-world and synthetic data experiments","volume":"47","author":"Tian","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.heliyon.2023.e21891_bib45","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1073\/pnas.1510502113","article-title":"Characterizing treatment pathways at scale using the OHDSI network","volume":"113","author":"Hripcsak","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2023.e21891_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/YCO.0000000000000808","article-title":"Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia","volume":"35","author":"Stuhec","year":"2022","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e21891_bib47","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/medicina58111584","article-title":"Polypharmacy management of antipsychotics in patients with Schizophrenia","volume":"58","author":"Kamei","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.heliyon.2023.e21891_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/acps.12222","article-title":"Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome","volume":"130","author":"Su","year":"2014","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023090990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023090990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:18:33Z","timestamp":1791292713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023090990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023090990"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21891","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21891"}}